CRVS

9.6703.40%
RA

Richard A. van den Broek

Independent Director

Mr. Richard A. van den Broek, CFA, also known as Rich, serves as Independent Director at Corvus Pharmaceuticals, Inc. from April 8, 2025. He is a Director of Pulse Biosciences, Inc. since August 06, 2020. He was a Member of Advisory Board at Cancer Focus Fund, LP. He has been a Director at PhaseBio Pharmaceuticals, Inc. since February 27, 2019. Mr. van den Broek founded HSMR Advisors, LLC and has been its Managing Partner since February 2004. Mr. van den Broek served as a Principal/Partner of Cooper Hill Partners, LLC from 2000 to 2003. He joined Cooper Hill Partners in May 2000. He served as an Executive Vice President of Cooper Hill Partners, LLC from 2000 to 2004. He served as an Equity Analyst of J.P. Morgan H&Q Principals, LP, Research Division, BofA Merrill Lynch, Research Division and JP Morgan Chase & Co, Research Division. He served with JP Morgan Chase as Managing Director and Senior Biotechnology Analyst. Mr. van den Broek was Investment Professional of Advantage Advisers Management LLC. He served as Vice President and Biotechnology Analyst of BofA Merrill Lynch and Oppenheimer & Co. He served as a Biotech Analyst of Hambrecht and Quist Capital Management, LLC. He had been an Independent Non-Executive Director of Cogstate Ltd. since August 26, 2010 until May 21, 2025. He had been a Director of Pharmacyclics Inc. since December 2009 until April 2015. He served as a Director of Celldex Therapeutics, Inc. since December 2014 until December 14, 2016. He served as a Director of Response Genetics, Inc. from December 2010 to October 9, 2015. He served as a Director of Special Diversified Opportunities Inc. from March 12, 2008 to October 19, 2015 and served as its Lead Director. He served as Non-Executive Director of Pharmaxis Ltd. from April 7, 2009 to September 2013. He served as a Director of Dyadic International Inc. He researched viruses at Harvard Medical School from 1988 to 1991. He is a Chartered Financial Analyst. Mr. van den Broek received an A.B. from Harvard University.

Positions